• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Chronic Urticaria (CU)
Trial Solutions

Enhancing study success with advanced clinical research technologies and expert solutions for Chronic Urticaria trials.

DOWNLOAD BROCHURE GET IN TOUCH

Effective solutions for advancing Chronic Urticaria research

Despite the availability of a variety of therapeutic options for chronic urticaria (CU), people living with this condition may not tolerate them well while others may require more effective alternatives. Now you can leverage comprehensive clinical research technology solutions within our Signant SmartSignals platform as well as our in-house clinical science expertise to help you deliver new therapies and treatment options.

Why Signant Health

  • Capture Better PRO Data
  • Optimize Endpoint Reliability
  • Launch Studies Faster
  • Digitalize Your Research
  • Conduct Global Studies
  • Capture Better PRO Data

    Capture Better PRO Data

    Signant SmartSignals eCOA enables electronic administration of chronic urticaria symptom diaries, UCT, and other CU assessments to help researchers generate better-quality ePRO data while simplifying the assessment experience for participants. Our clinical and eCOA scientists support your study by advising on diary design, assessment selection and implementation, and best practices.
     

  • Optimize Endpoint Reliability

    Optimize Endpoint Reliability

    Ensure reliable endpoint data: Our Outcome Analytics solution offers statistical monitoring and data visualization to identify quality concerns that could impact endpoint reliability such as errors or fraud. Our clinical and data scientists help your team review the data and recommend mitigation strategies to mitigate data concerns, preventing bad data quality from compromising your study results.
     

  • Launch Studies Faster

    Launch Studies Faster

    Accelerate the study startup process by obtaining informed consent, enrolling, and randomizing participants faster using our Signant SmartSignals RTSM and eConsent solutions. Both include options that allow for rapid deployment and simplified implementation of protocol amendments. Plus, these solutions facilitate decentralized study designs.
     

  • Digitalize Your Research

    Digitalize Your Research

    Each solution and service within our Signant SmartSignals evidence generation suite can be applied to a study independently. However, when combined, they create an intuitive and powerful digital ecosystem for creating and managing complex global studies. Plus, every study is supported by a dedicated team of clinical science and operations experts experienced in this indication.
     

  • Conduct Global Studies

    Conduct Global Studies

    Reach the participants you need to meet enrollment goals by employing solutions that facilitate remote study activities. From RTSM to eConsent, eCOA, and Telemedicine, Signant's comprehensive range of solutions and global project teams will help you conduct trial activities anywhere and any way.
     

Comprehensive Chronic Urticaria experience

0

STUDIES

0

PATIENTS

0

COUNTRIES

0

SITES

Explore our Chronic Urticaria trial resources
SOLUTION BROCHURE

Chronic Urticaria Trial Solutions Overview


GET INSIGHTS
VIDEO

Chronic Urticaria Trial Solutions


WATCH [2 MIN]
WEBINAR

Improving Data Quality in Dermatology Trials

 
WATCH NOW

eClinical solutions for Chronic Urticaria trials

Ready to learn more?

Discover how Signant can support your current or upcoming chronic urticaria trials. 

DOWNLOAD BROCHURE GET STARTED